This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/chebi/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/kegg-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03127/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03127
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03127 n9:DB03127
dcterms:title
Benzamidine
adms:identifier
n8:41033 n11:BAM n12:444655 n13:DB03127 n14:C01784 n15:46504844
n3:synthesisReference
Takayuki Hara, Toru Minoshima, Masayasu Tabe, "Benzamidine derivatives and process for production thereof." U.S. Patent US20050101675, issued May 12, 2005.
n3:IUPAC-Name
n4:271B51A2-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B51A8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B51A7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B51A4-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B51A5-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B51A6-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B51A0-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B51A1-363D-11E5-9242-09173F13E4C5 n4:271B519E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B519F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B51AE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B51AF-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B51A9-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B51AA-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B51AC-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B51AB-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B51AD-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
618-39-3
n3:Bioavailability
n4:271B51B3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B51B5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B51B6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B51B2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B51B1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B51B4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B51A3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B51B0-363D-11E5-9242-09173F13E4C5